Last updated on November 2018

An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice

Brief description of study

This study, a national, multicenter, observational, ambispective, non-interventional study, will be conducted in French hospitals prescribing pomalidomide and already participating in the ongoing Imnovid registry.

This study will add to the registry. Indeed, pomalidomide-prescribing physicians and pharmacists dispensing pomalidomide have to enter into the Imnovid registry all patients who have been prescribed this drug since the date on which it was marketed regardless of the initiation date of pomalidomide or the indication for which it was prescribed.

Clinical Study Identifier: NCT02902900

Contact Investigators or Research Sites near you

Start Over

Associate Director Clinical Trial Disclosure

Institut de Canc rologie de la Loire
St Priest En Jarez Cedex, France
  Connect »

Associate Director Clinical Trial Disclosure

H pital Nord
St Priest En Jarez, France
  Connect »